Legato Capital Management »

Silverback Therapeutics shares owned by Legato Capital Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Legato Capital Management from 13F filings

Historical chart of Legato Capital Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Legato Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Legato Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $396k 39k 10.05
2025-06-30 $1.8M 104k 17.45
2025-03-31 $1.2M 97k 12.58
2024-12-31 $226k 22k 10.55
2024-09-30 $353k 24k 14.50